UBS Group’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-400
| Closed | -$3.94K | – | 9782 |
|
|
2022
Q4 | $3.94K | Buy |
+400
| New | +$3.94K | ﹤0.01% | 8228 |
|
|
2022
Q3 | – | Sell |
-199
| Closed | -$2K | – | 10157 |
|
|
2022
Q2 | $2K | Sell |
199
-600
| -75% | -$6.03K | ﹤0.01% | 8678 |
|
|
2022
Q1 | $8K | Buy |
799
+600
| +302% | +$6.01K | ﹤0.01% | 7696 |
|
|
2021
Q4 | $2K | Sell |
199
-1,209
| -86% | -$12.2K | ﹤0.01% | 8759 |
|
|
2021
Q3 | $14K | Buy |
1,408
+30
| +2% | +$298 | ﹤0.01% | 6481 |
|
|
2021
Q2 | $14K | Sell |
1,378
-1,300
| -49% | -$13.2K | ﹤0.01% | 6636 |
|
|
2021
Q1 | $27K | Buy |
2,678
+930
| +53% | +$9.38K | ﹤0.01% | 6099 |
|
|
2020
Q4 | $19K | Buy |
+1,748
| New | +$19K | ﹤0.01% | 5985 |
|